Bio

Eric Zitter focuses on deal origination with a focus on domestic and cross-border mergers and acquisitions. Eric has researched and traveled globally searching for M&A opportunities for Achelous Partners’ international client base. Previously, Eric was a Business Development Analyst at Quintiles Transnational, where he conducted research on potential blockbuster late Phase III/registered drugs as targets for new business opportunities, analyzed competitor companies as targets for possible acquisitions, and launched the company’s first weekly internal newsletter consisting of latest drug news, new drug approvals, and pipeline information. Eric holds a joint Bachelor of Science and Engineering in Bioengineering with a minor in Applied Economics from Cornell University.